OCC 2.63% 39.0¢ orthocell limited

Stem Cell Therapy advancements, page-375

  1. 1,381 Posts.
    lightbulb Created with Sketch. 227
    2021, I asked at the AGM who they were in talks with Otho-ATI, response, we are in talk with a few big pharmaceutical companies including J&J.

    From memory J&J study was over within the next few months, so here we are 16 months later, you guessed it, still nothing.

    So what do management do, their hands are tied, lips are sealed, let’s do another study, rotor cuff and tennis elbow, no collaboration with BP ( what we know of ) things just don’t add up for this company, they never really have. Then all of a sudden they have sign a global partnership like the one for Striate+.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
0.010(2.63%)
Mkt cap ! $81.63M
Open High Low Value Volume
37.5¢ 39.0¢ 37.5¢ $49.66K 129.0K

Buyers (Bids)

No. Vol. Price($)
3 20305 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 77938 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.